RNA m1A methylation regulates glycolysis of cancer cells through modulating ATP5D

Yingmin Wu1,2, Zhuojia Chen3, Guoyou Xie1

  • 1Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.

Insights

N1-methyladenosine (m1A) demethylase ALKBH3 regulates cancer cell glycolysis by targeting ATP5D. This RNA modification impacts tumor growth and cancer progression, revealing a link between mRNA metabolism and cancer therapeutics.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • While N6-methyladenosine (m6A) modifications in mRNA are well-studied, the role of N1-methyladenosine (m1A) in cancer progression is largely unknown.
  • Understanding RNA modifications' impact on cellular metabolism is crucial for developing novel cancer therapies.

Purpose of the Study:

  • To investigate the role of m1A demethylase ALKBH3 in cancer cell glycolysis.
  • To elucidate the mechanism by which ALKBH3 regulates cancer cell metabolism and tumor growth.

Main Methods:

  • Investigated ALKBH3's demethylase activity in cancer cell glycolysis.
  • Utilized sequencing and functional studies to identify ATP5D as a key regulator.
  • Employed the dm1ACRISPR system for targeted demethylation of ATP5D m1A.
  • Performed in vivo experiments to assess the role in tumor growth.

Main Results:

  • ALKBH3 regulates cancer cell glycolysis in a demethylation-dependent manner.
  • m1A modification at A71 of ATP5D negatively impacts its translation elongation via YTHDF1/eRF1 complex.
  • m1A also affects E2F1 mRNA stability, influencing ATP5D transcription.
  • Targeted demethylation of ATP5D m1A enhances ATP5D expression and glycolysis, promoting tumor growth.

Conclusions:

  • Reveals a novel mechanism linking mRNA m1A modification, specifically of ATP5D, to cancer cell glycolysis and progression.
  • Highlights the interplay between RNA modification and cell metabolism as a potential therapeutic target in cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
160